You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Novo Nordisk challenges Pfizer in billion-dollar battle for Metsera
Text:
Kim Liedholm | [email protected]
Novo Nordisk has made a bid worth up to USD 9 billion for the American company Metsera – just weeks after Pfizer presented its own acquisition offer. This intensifies the battle...